These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors. Goh SSL; Lai PSM; Tan ATB; Ponnampalavanar S Osteoporos Int; 2018 Mar; 29(3):595-613. PubMed ID: 29159533 [TBL] [Abstract][Full Text] [Related]
48. Management of bone mineral density in HIV-infected patients. Negredo E; Bonjoch A; Clotet B Expert Opin Pharmacother; 2016; 17(6):845-52. PubMed ID: 26809940 [TBL] [Abstract][Full Text] [Related]
49. Part I: Which Child with a Chronic Disease Needs Bone Health Monitoring? Ward LM Curr Osteoporos Rep; 2021 Jun; 19(3):278-288. PubMed ID: 34245406 [TBL] [Abstract][Full Text] [Related]
50. It is time for everyone to own the bone. Bunta AD Osteoporos Int; 2011 Aug; 22 Suppl 3():477-82. PubMed ID: 21847769 [TBL] [Abstract][Full Text] [Related]
51. Osteopenia: debates and dilemmas. Zhang J; Morgan SL; Saag KG Curr Rheumatol Rep; 2013 Dec; 15(12):384. PubMed ID: 24222198 [TBL] [Abstract][Full Text] [Related]
52. Prospective risk of osteoporotic fractures in patients with advanced chronic obstructive pulmonary disease. Gupta A; Greening NJ; Evans RA; Samuels A; Toms N; Steiner MC Chron Respir Dis; 2019; 16():1479972318769763. PubMed ID: 29661041 [TBL] [Abstract][Full Text] [Related]
53. Screening for osteoporosis: recommendation statement. U.S. Preventive Services Task Force Am Fam Physician; 2011 May; 83(10):1197-200. PubMed ID: 21568254 [No Abstract] [Full Text] [Related]
54. Gender differences for initiating teriparatide therapy: baseline data from the Direct Assessment of Nonvertebral Fracture in the Community Experience (DANCE) study. Wong M; Wan X; Ruff V; Krohn K; Taylor K Osteoporos Int; 2012 Apr; 23(4):1445-52. PubMed ID: 21769662 [TBL] [Abstract][Full Text] [Related]
55. Fracture prevention in Kaiser Permanente Southern California. Dell R Osteoporos Int; 2011 Aug; 22 Suppl 3():457-60. PubMed ID: 21847765 [TBL] [Abstract][Full Text] [Related]
56. Osteoporosis prevalence and characteristics of treated and untreated nursing home residents with osteoporosis. Zarowitz BJ; Cheng LI; Allen C; O'Shea T; Stolshek B J Am Med Dir Assoc; 2015 Apr; 16(4):341-8. PubMed ID: 25726417 [TBL] [Abstract][Full Text] [Related]
57. Osteoporosis: a still increasing prevalence. Reginster JY; Burlet N Bone; 2006 Feb; 38(2 Suppl 1):S4-9. PubMed ID: 16455317 [TBL] [Abstract][Full Text] [Related]
58. Teriparatide persistence and tolerance in patients with osteoporosis: Observational data from clinical practice. Taisne N; Mignot MA; Legroux I; Cortet B; Paccou J Joint Bone Spine; 2018 Oct; 85(5):641-642. PubMed ID: 29407040 [No Abstract] [Full Text] [Related]
59. The efficacy of calcitriol therapy in the management of bone loss and fractures: a qualitative review. Peppone LJ; Hebl S; Purnell JQ; Reid ME; Rosier RN; Mustian KM; Palesh OG; Huston AJ; Ling MN; Morrow GR Osteoporos Int; 2010 Jul; 21(7):1133-49. PubMed ID: 19960185 [TBL] [Abstract][Full Text] [Related]